APECED: Is this a model for failure of T cell and B cell tolerance?

Frontiers in Immunology

Volumn 3, Issue AUG, 2012, Pages

  Kluger, Nicolas ^a   Ranki, Annamari ^a   Krohn, Kai ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

AIRE; APECED; Endocrine disorders; Interleukin 17; Interleukin 22; IPEX; T regulatory cells

Indexed keywords

EID: 84874210467     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00232     Document Type: Article

References (92)

1. Ahonen,P., MySllarniemi, S., Sipila, I.,and Perheentupa, J. (1990). Clinical variation of autoimmune polyendocrinopathycandidiasisectodermal dystrophy (APECED) in a series of 68 patients. N. Engl. J. Med. 322, 1829-1836.
2. Akirav, E. M., Ruddle, N. H., and Herold, K. C. (2011). The role of AIREinhumanautoimmunedisease. Nat. Rev. Endocrinol. 7,25-33.
3. Andrada, J. A., Bigazzi, P. L., Andrada, E., Milgrom, F., and Witebsky, E. (1968). Serological investigations on Addison's disease. JAMA 206, 1535-1541.
4. Bacchetta, R., Passerini, L., Gambineri, E., Dai, M., Allan, S. E., Perroni, L., Dagna-Bricarelli, F., Sartirana, C., Matthes-Martin, S., Lawitschka, A., Azzari, C., Ziegler, S. F., Levings, M. K., and Roncarolo, M. G. (2006). Defective regulatory and effector T cell functions in patients with FOXP3mutations.J.Clin.Invest.116, 1713-1722.
5. Bennett, C. L., Yoshioka, R., Kiyosawa, H., Barker, D. F., Fain, P. R., Shigeoka, A. O., and Chance, P. F. (2000). X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3. Am. J. Hum. Genet. 66,461-468.
6. Betterle, C., and Zanchetta, R. (2003). Update on autoimmune polyendocrine syndromes (APS). Acta Biomed. 74,9-33.
7. Bjorses, P., Alltonen, J., Vikman, A., Perheentupa, J., Ben-Zion, G., Chiumello, G., Dahl, N., Heidemen, P., Hoorweg-Nijman, J. J., Mathivon, L., Mullis, P. E., Pohl, M., Ritzen, M., Romeo, G., Shapiro, M. S., Smith, C. S.,Solyom,J.,Zlotogora,J.,andPeltonen, L. (1996). Genetic homogeneity of autoimmune polyglandular disease type I. Am. J. Hum. Genet. 59, 879-886.
8. Björses, P., Halonen, M., Palvimo, J. J., Kolmer, M., Aaltonen, J., Ellonen, P., Perheentupa, J., Ulmanen, I., and Peltonen, L. (2000). Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathycandidiasisectodermal dystrophy protein. Am. J. Hum. Genet. 66,378-392.
9. Blizzard, R. M., Tomasi, T. B., and Christy, N. P. (1963). Autoantibodies against thyroid and adrenal tissue in a patient with mutiple, primary endocrine deficiencies. J. Clin. Endocrinol. Metab. 23,1179-1180.
10. Blizzard, R. M., Chandler, R. W., Kyle, M. A., and Hung, W. (1962). Adrenal antibodies in Addison's disease. Lancet 2, 901-903.
11. Bottazzo,G.F.,Dean,B.M.,Gorsuch,A. N.,Cudworth,A.G.,andDoniach,D. (1980). Complementfixing isletcell antibodiesintype-Idiabetes:possible monitors of active betacell damage. Lancet 1, 668-672.
12. Bratland, E., Skinningsrud, B., Undlien, D. E., Mozes, E., and Husebye, E. S. (2009). T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency. J. Clin. Endocrinol. Metab. 12, 5117-5124.
13. Brun, J. M. (1978). Autoimmune juvenile polyendocrinopathy (author's transl). Ann. Endocrinol. (Paris) 39, 463-481.
14. Collins, S. M., Dominguez, M., Ilmarinen, T., Costigan, C., and Irvine, A.D. (2006). Dermatological manifestations of autoimmune polyendocrinopathycandidiasisectodermal dystrophy syndrome. Br. J. Dermatol. 154,1088-1093.
15. Derbinski, J., Gäbler, J., Brors, B., Tierling, S., Jonnakuty, S., Hergenhahn, M., Peltonen, L., Walter, J., and Kyewski,B. (2005). Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J. Exp. Med. 202,33-45.
16. DeVoss, J. J., LeClair, N. P., Hou, Y., Grewal, N. K., Johannes, K. P., Lu, W., Yang, T., Meagher, C., Fong, L., Strauss, E. C., and Anderson, M. S. (2010). An autoimmune response to odorant binding protein 1a is associated with dryeye in the Airedeficient mouse. J. Immunol. 184, 4236-4246.
17. D'Hennezel,E.,Ben-Shoshan,M.,Ochs, H. D., Torgerson, T. R., Russell, L. J., Lejtenyi, C., Noya, F. J., Jabado, N., Mazer,B.,andPiccirillo,C.A.(2009). FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome. N. Engl. J. Med. 361, 1710-1713.
18. Doniach, D., and Roitt, I. M. (1964). An evaluation of gastricandthyroidautoimmunityinrelatation to hematologic autoimmunity. Semin. Hematol. 1, 313-343.
19. Ekwall,O.,Hedstrand,H.,Grimelius,L., Haavik, J., Perheentupa, J., Gustafsson, J., Husebye, E., Kämpe, O., and Rorsman, F. (1998). Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 352, 279-283.
20. Endharti, A. T., Okuno, Y., Shi, Z., Misawa, N., Toyokuni, S., Ito, M., Isobe, K., and Suzuki, H. (2011). CD8+CD122+ regulatory T cells (Tregs) and CD4+ Tregs cooperatively prevent and cure CD4+ cellinduced colitis. J. Immunol. 186, 41-52.
21. Engelhardt, K. R., and Grimbacher, B. (2012). Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects. J. Allergy Clin. Immunol. 129, 294-305.
22. Fierabracci, A. (2011). Recent insights into the role and molecular mechanisms of the autoimmune regulator (AIRE) gene in autoimmunity. Autoimmu. Rev. 10, 137-143.
23. Gardner,J.M.,Fletcher,A.L.,Anderson, M.S.,andTurley,S.J. (2009).AIREin the thymus and beyond. Curr. Opin. Immunol. 21,582-589.
24. Gavalas, N. G., Kemp, E. H., Krohn, K. J., Brown, E. M., Watson, P. F., and Weetman, A. P. (2007). The calciumsensingreceptorisatargetof autoantibodiesinpatientswithautoimmune polyendocrine syndrome type 1. J. Clin. Endocrinol. Metab. 92, 2107-2114.
25. Gavanescu, I., Benoist, C., and Mathis, D. (2008). B cells are required for Airedeficient mice to develop multiorganautoinflammation:atherapeutic approach for APECED patients. Proc. Natl. Acad. Sci. U.S.A. 105, 13009-13014.
26. Gringhuis, S. I., Kaptein, T. M., Wevers, B. A., Theelen, B., van der Vlist, M., Boekhout, T., and Geijtenbeek, T. B. (2012). Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome. Nat. Immunol. 13, 246-254.
27. Hannigan,N. R.,Jabs,K.,Perez-Atayde, A. R., and Rosen, S. (1996). Autoimmune interstitial nephritis and hepatitis in polyglandular autoimmune syndrome. Pediatr. Nephrol. 10, 511-514.
28. Heath, W. R., and Carbone, F. R. (2009). Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat. Immunol. 10, 1237-1244.
29. Heinonen, E., Krohn, K., Perheentupa, J., Aro, A., and Pelkonen, R. (1976). Association of precipitating antiadrenal antiadrenal antibodies with moniliasispolyendocrinopathy syndrome. Ann. Clin. Res. 8, 262-265.
30. Husebye, E. S., Perheentupa, J., Rautemaa,R.,and Kämpe,O. (2009). Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J. Intern. Med. 265,514-529.
31. Irvine, W. J., Davies, S. H., Teitelbaum, S., Delamore, I. W., and Williams, A. W.(1965).Theclinicalandpathologicalsignificanceof gastricparietalcell antibody. Ann. N. Y. Acad. Sci. 124, 657-691.
32. Irvine, W. J., MacGregor, A. G., and Stuart, A. E. (1962). The prognostic significance of thyroid antibodies in the management of thyrotoxicosis. Lancet 2, 843-847.
33. Jefferies, C., Wynne, C., and Higgs, R. (2011). Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease? Nat. Rev. Immunol. 11,617-625.
34. Jeffries, G. H., Hoskins, D. W., and Sleisenger, M. H. (1962). Antibody to intrinsic factor in serum from patients with pernicious anemia. J. Clin. Invest. 41, 1106-1115.
35. Kaldany, A. (1979). Autoantibodies to islet cells in diabetes mellitus. Diabetes 28,102-105.
36. Karlsson, F. A., Burman, P., Lööf, L., and Mårdh, S. (1988). Major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acidproducing H+,K+-adenosine triphosphatase of the stomach. J. Clin. Invest. 81, 475-479.
37. Kekäläinen, E., Tuovinen, H., Joensuu, J., Gylling, M., Franssila, R., Pöntynen,N.,Talvensaari,K.,Perheentupa, J., Miettinen, A., and Arstila, T. P. (2007). A defect of regulatory T cells in patients with autoimmune polyendocrinopathycandidiasisectodermal dystrophy. J. Immunol. 178,1208-1215.
38. Kemp, E. H., Gavalas, N. G., Akhtar, S., Krohn, K. J., Pallais, J. C., Brown, E. M.,Watson, P. F., and Weetman,A. P. (2010). Mapping of human autoantibody binding sites on the calciumsensing receptor. J. Bone Miner. Res. 25,132-140.
39. Kemp, E. H., Gavalas, N. G., Krohn, K. J., Brown, E. M., Watson, P. F., and Weetman, A. P. (2009). Activating autoantibodies against the calciumsensing receptor detected in two patients with autoimmune polyendocrine syndrome type 1. J. Clin. Endocrinol. Metab. 94, 4749-4756.
40. Kisand, K., Lilic, D., Casanova, J. L., Peterson, P., Meager, A., and Willcox, N. (2011). Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications. Eur. J. Immunol. 41, 1517-1527.
41. Kogawa, K., Nagafuchi, S., Katsuta, H., Kudoh, J., Tamiya, S., Sakai, Y., Shimizu, N., and Harada, M. (2002). Expression of AIRE gene in peripheral monocyte/dendritic cell lineage. Immunol. Lett. 80,195-198.
42. Krohn, K., Perheentupa, J., and Heinonen, E. (1974). Precipitating antiadrenal antibodies in Addison's disease. Clin. Immunol. Immunopathol. 3,59-68.
43. Laakso, S. M., Laurinolli, T. T., Rossi, L. H., Lehtoviita, A., Sairanen, H., Perheentupa, J., Kekäläinen, E., and Arstila,T. P. (2010). Regulatory T cell defect in APECED patients is associated with loss of naive FOXP3(+) precursors and impaired activated population. J. Autoimmun. 35, 351-357.
44. Laakso, S. M., Kekäläinen, E., Rossi, L. H., Laurinolli, T. T., Mannerström, H., Heikkilä, N., Lehtoviita, A., Perheentupa, J., Jarva, H., and Arstila, T. P. (2011). IL-7 dysregulation and loss of CD8+ T cell homeostasis in the monogenic human disease autoimmune polyendocrinopathycandidiasisectodermal dystrophy. J. Immunol. 187,2023-2030.
45. Lehtoviita, A., Rossi, L. H., Kekäläinen, E., Sairanen, H., and Arstila, T. P. (2009). The CD4(+)CD8(+) and CD4(+) subsets of FOXP3(+)thymocytes differ in their response to growth factor deprivation or stimulation. Scand. J. Immunol. 70, 377-383.
46. Matsumoto, M. (2011). Contrasting models for the roles of Aire in the differentiation program of epithelial cells in the thymic medulla.Eur.J. Immunol. 41, 12-17.
47. Meager, A., Visvalingam, K., Peterson, P., Möll, K., Murumägi, A., Krohn, K., Eskelin, P., Perheentupa, J., Husebye, E., Kadota, Y., and Willcox, N. (2006). Antiinterferon autoantibodies in autoimmunepolyendocrinopathysyndrome type 1. PLoS Med. 3, e289. doi: 10.1371/journal.pmed.0030289
48. Meloni, A., Willcox, N., Meager, A., Atzeni, M., Wolff, A. S., Husebye, E. S., Furcas, M., Rosatelli, M. C., Cao, A., and Congia, M. (2012). Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients. J. Clin. Endocrinol. Metab. 97, 1114-1124.
49. Merenmies, L., and Tarkkanen, A. (2000). Chronic bilateral keratitis in autoimmune polyendocrinopathycandidiadisectodermal dystrophy (APECED). A longterm followup and visual prognosis. Acta Ophthalmol. Scand. 78,532-535.
50. Merrill, J. T., Wallace, D. J., Petri, M., Kirou, K. A., Yao, Y., White, W. I., Robbie, G., Levin, R., Berney, S. M., Chindalore, V., Olsen, N., Richman, L,. Le, C., Jallal, B., and White, B.; Lupus Interferon Skin Activity (LISA) Study Investigators. (2011). Safety profile and clinical activity of sifalimumab, a fully human antiinterferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, doubleblind randomised study. Ann. Rheum. Dis. 70, 1905-1913.
51. Moraes-Vasconcelos, D., Costa-Carvalho, B. T., Torgerson, T. R., and Ochs, H. D. (2008). Primary immune deficiency disorders presenting as autoimmune diseases: IPEXandAPECED.J.Clin. Immunol. 28, S11-S19.
52. Nagamine, K., Peterson, P., Scott, H. S., Kudoh, J., Minoshima, S., Heino, M., Krohn, K. J., Lalioti, M. D., Mullis, P. E., Antonarakis, S. E., Kawasaki, K., Asakawa, S., Ito, F., and Shimizu, N. (1997). Positional cloning of the APECED gene. Nat. Genet. 17, 393-398.
53. Neufeld, M., Maclaren, N. K., and Blizzard, R. M. (1981). Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore) 60, 355-362.
54. Obermayer-Straub, P., Perheentupa, J., Braun,S.,Kayser,A.,Barut,A.,Loges, S., Harms, A., Dalekos, G., Strassburg, C. P., and Manns, M. P. (2001). Hepaticautoantigensinpatientswith autoimmune polyendocrinopathycandidiasisectodermal dystrophy. Gastroenterology 121,668-677.
55. Ohsie, S., Gerney, G., Gui, D., Kahana, D., Martín, M. G., and Cortina, G. (2009). A paucity of colonic enteroendocrine and/or enterochromaffin cells characterizes a subset of patients with chronic unexplained diarrhea/malabsorption. Hum. Pathol. 40,1006-1014.
56. Oliva-Hemker, M., Berkenblit, G. V., Anhalt,G.J.,andYardley,J.H. (2006). Pernicious anemia and widespread absence of gastrointestinal endocrine cells in a patient with autoimmune polyglandular syndrome type I and malabsorption. J. Clin. Endocrinol. Metab. 91,2833-2838.
57. Orlova, E. M., Bukina, A. M., Kuznetsova, E. S., Kareva, M. A., Zakharova, E. U., Peterkova, V. A., and Dedov, I. I. (2010). Autoimmunepolyglandularsyndrometype1 in Russian patients: clinical variants and autoimmune regulator mutations. Horm. Res. Paediatr. 73, 449-457.
58. Padeh, S., Theodor, R., Jonas, A., and Passwell, J. H. (1997). Severe malabsorption in autoimmune polyendocrinopathycandidosisectodermal dystrophy syndrome successfully treated with immunosuppression. Arch. Dis. Child. 76, 532-534.
59. Pavlic,A.,andWaltimo-Sirén,J. (2009). Clinical and microstructural aberrations of enamel of deciduous and permanent teeth in patients with autoimmune polyendocrinopathycandidiasisectodermal dystrophy. Arch. Oral Biol. 54,658-665.
60. Pedroza, L. A., Kumar, V., Sanborn, K. B., Mace, E. M., Niinikoski, H., Nadeau, K., Vasconcelos Dde, M., Perez, E., Jyonouchi, S., Jyonouchi, H., Banerjee, P. P., Ruuskanen, O., Condino-Neto, A., and Orange, J. S. (2012). Autoimmune regulator (AIRE) contributes to Dectin-1-induced TNF-α production and complexes with caspase recruitment domaincontaining protein 9 (CARD9), spleen tyrosine kinase (Syk), and Dectin-1. J. Allergy Clin. Immunol. 129, 464-472, 472.e1-3.
61. Perheentupa, J. (2002). APS-I/APECED: the clinical disease and therapy. Endocrinol. Metab. Clin. North Am. 31,295-320,vi.
62. Perheentupa, J. (2006). Autoimmune polyendocrinopathycandidiasisectodermal dystrophy. J. Clin. Endocrinol. Metab. 91,2843-2850.
63. Pollak,U.,Bar-Sever,Z.,Hoffer,V.,Marcus, N., Scheuerman, O., and Garty, B. Z. (2009). Asplenia and functional hyposplenismin autoimmunepolyglandular syndrome type 1. Eur. J. Pediatr. 168,233-235.
64. Popler, J., Alimohammadi, M., Kämpe, O.,Dalin,F.,Dishop,M. K.,Barker,J. M., Moriarty-Kelsey, M., Soep, J. B., andDeterding,R.R. (2012).Autoimmune polyendocrine syndrome type Utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab. Pediatr. Pulmonol. 47, 84-87.
65. Posovszky,C.,Lahr,G.,vonSchnurbein, J., Buderus, S., Findeisen, A., Schröder, C., Schütz, C., Schulz, A, Debatin, K. M., Wabitsch, M., and Barth, T. F. (2012). Loss of enteroendocrine cells in autoimmunepolyendocrinecandidiasisectodermaldystrophy (APECED) syndrome with gastrointestinal dysfunction. J. Clin. Endocrinol. Metab. 97, E292-E300.
66. Powell,B.R.,Buist,N.R.,andStenzel,P. (1982).AX-linkedsyndromeof diarrhea, polyendocrinopathy, and fatal infection in infancy. J. Pediatr. 100, 731-737.
67. Ramsey, C., Winqvist, O., Puhakka, L., Halonen, M., Moro, A., Kämpe, O., Eskelin, P., Pelto-Huikko, M., and Peltonen, L. (2002). Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum. Mol. Genet. 11,397-409.
68. Rautemaa, R., Hietanen, J., Niissalo, S., Pirinen, S., and Perheentupa, J. (2007). Oral and oesophageal squamous cell carcinomaacomplicationorcomponentof autoimmune polyendocrinopathycandidiasisectodermal dystrophy (APECED, APS-I). Oral Oncol. 43, 607-613.
69. Reimand, K., Perheentupa, J., Link, M., Krohn, K., Peterson, P., and Uibo, R. (2008). Testisexpressed protein TSGA10 an autoantigen in autoimmune polyendocrine syndrome type I. Int. Immunol. 20,39-44.
70. Rosatelli, M. C., Meloni, A., Meloni, A., Devoto, M., Cao, A., Scott, H. S., Peterson, P., Heino, M., Krohn, K. J., Nagamine, K., Kudoh, J., Shimizu, N., and Antonarakis, S. E. (1998). A common mutation in Sardinian autoimmune polyendocrinopathycandidiasisectodermal dystrophy patients. Hum. Genet. 103, 428-434.
71. Rottembourg,D.,Deal,C.,Lambert,M., Mallone, R., Carel, J. C., Lacroix, A., Caillat-Zucman, S., and le Deist, F. (2010). 21-Hydroxylase epitopes are targeted by CD8 T cells in autoimmune Addison's disease. J. Autoimmun. 35, 309-315.
72. Ryan, K. R., Lawson, C. A., Lorenzi, A. R., Arkwright, P. D., Isaacs, J. D., and Lilic, D. (2005) CD4+CD25+ T-regulatory cells are decreased in patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. J. Allergy Clin. Immunol. 116,1158-1159.
73. Saitoh,O.,Abiru,N.,Nakahara,M.,and Nagayama,Y. (2007).CD8+CD122+ T cells, a newly identified regulatory T subset, negatively regulate Graves' hyperthyroidism in a murine model. Endocrinology 148,6040-6046.
74. Schaller, C. E., Wang, C. L., Beck-Engeser, G., Goss, L., Scott, H. S., Anderson, M. S., and Wabl, M. (2008). Expression of Aire and the early wave of apoptosis in spermatogenesis. J. Immunol. 180, 1338-1343.
75. Schwartz, M. (1961). Antibodies to intrinsic factor. Acta Allergol. 16, 263-266.
76. Si, L., Whiteside, T. L., Van Thiel, D. H., and Rabin, B. S. (1984). Lymphocyte subpopulations at the site of "piecemeal" necrosis in end stagechronicliverdiseasesandrejecting liver allografts in cyclosporinetreated patients. Lab. Invest. 50, 341-347.
77. Sköldberg, F., Portela-Gomes, G. M., Grimelius, L., Nilsson, G., Perheentupa, J., Betterle, C., Husebye, E. S., Gustafsson, J., Rönnblom, A., Rorsman, F., and Kämpe, O. (2003). Histidine decarboxylase, a pyridoxal phosphatedependent enzyme, is an autoantigen of gastric enterochromaffinlike cells. J. Clin. Endocrinol. Metab. 88, 1445-1452.
78. Soderbergh, A., Myhre, A. G., Ekwall, O., Gebre-Medhin, G., Hedstrand, H., Landgren, E., Miettinen, A., Eskelin, P., Halonen, M., Tuomi, T., Gustafsson, J., Husebye, E. S., Perheentupa, J., Gylling, M., Manns, M. P., Rorsman, F., Kämpe, O., and Nilsson, T. (2004). Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J. Clin. Endocrinol. Metab. 89, 557-562.
79. The Finnish-German APECED Consortium. (1997). An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zincfinger domains. Nat. Genet. 17, 399-403.
80. Toh,B. H.,van Driel,I. R.,and Gleeson, P. A. (1997). Pernicious anemia. N. Engl.J.Med.337,1441-1448.
81. Torgerson, T. R., Linane, A., Moes, N., Anover, S., Mateo, V., Rieux-Laucat, F., Hermine, O., Vijay, S., Gambineri, E., Cerf-Bensussan, N., Fischer, A., Ochs, H. D., Goulet, O., and Ruemmele, F. M. (2007). Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene. Gastroenterology 132, 1705-1717.
82. Uibo, R., Aavik, E., Peterson, P., Perheentupa,J.,Aranko,S.,Pelkonen,R., and Krohn, K. J. (1994a). Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. J. Clin. Endocrinol. Metab. 78, 323-328.
83. Uibo, R., Perheentupa, J., Ovod, V., and Krohn, K. J. (1994b). Characterization of adrenal autoantigens recognized by sera from patients withautoimmunepolyglandularsyndrome(APS)typeI.J.Autoimmun. 7, 399-411.
84. Uibo, R. M., and Krohn, K. J. (1984). Demonstration of gastrin cell autoantibodies in antral gastritis with avidinbiotin complex antibody technique. Clin. Exp. Immunol. 58, 341-347.
85. Walder, A. I., Lunseth, J. B., and Peter, E. T. (1963). Antibodies to the gastric parietal cell. Surg. Forum 14, 327-328.
86. Ward, L., Paquette, J., Seidman, E., Huot, C., Alvarez, F., Crock, P., Delvin, E., Kämpe, O., and Deal, C. (1999). Severe autoimmune polyendocrinopathycandidiasisectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J. Clin. Endocrinol. Metab. 84,844-852.
87. Warren, J. R., and Marshall, B. J. (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1, 1311-1315.
88. Waterfield, M., and Anderson, M. S. (2011). Autoimmunity's collateral damage: Immunodeficiency hints at autoreactivitytocytokines.Nat.Med. 17,1054-1055.
89. Winqvist, O., Gustafsson, J., Rorsman, F., Karlsson, F. A., and Kämpe, O. (1993). Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J. Clin. Invest. 92, 2377-2385.
90. Witebsky, E., Rose, N. R., Paine, J. R., and Egan, R. W. (1957). Thyroidspecific autoantibodies. Ann. N. Y. Acad. Sci. 69,669-677.
91. Wolff, A. S., Oftedal, B. E., Kisand, K., Ersvaer, E., Lima, K., and Husebye, E. S. (2010). Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I. Scand. J. Immunol. 71,459-467.
92. Zlotogora, J., and Shapiro, M. S. (1992). Polyglandular autoimmune syndrometypeIamongIranianJews. J. Med. Genet. 29, 824-826.